- Home
- IMCR vs FBK Comparison
IMCR vs FBK Comparison
Compare IMCR & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- FBK
- Stock Information
- Founded
- IMCR 2008
- FBK 1906
- Country
- IMCR United Kingdom
- FBK United States
- Employees
- IMCR N/A
- FBK N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- FBK Major Banks
- Sector
- IMCR Health Care
- FBK Finance
- Exchange
- IMCR Nasdaq
- FBK Nasdaq
- Market Cap
- IMCR 1.8B
- FBK 2.1B
- IPO Year
- IMCR 2021
- FBK 2016
- Fundamental
- Price
- IMCR $37.20
- FBK $53.64
- Analyst Decision
- IMCR Buy
- FBK Buy
- Analyst Count
- IMCR 9
- FBK 4
- Target Price
- IMCR $57.00
- FBK $58.50
- AVG Volume (30 Days)
- IMCR 284.7K
- FBK 389.2K
- Earning Date
- IMCR 11-05-2025
- FBK 10-14-2025
- Dividend Yield
- IMCR N/A
- FBK 1.40%
- EPS Growth
- IMCR N/A
- FBK N/A
- EPS
- IMCR N/A
- FBK 1.94
- Revenue
- IMCR $356,145,000.00
- FBK $410,807,000.00
- Revenue This Year
- IMCR $31.83
- FBK $35.00
- Revenue Next Year
- IMCR $8.50
- FBK $21.58
- P/E Ratio
- IMCR N/A
- FBK $27.91
- Revenue Growth
- IMCR 26.78
- FBK N/A
- 52 Week Low
- IMCR $23.15
- FBK $38.83
- 52 Week High
- IMCR $39.33
- FBK $58.88
- Technical
- Relative Strength Index (RSI)
- IMCR 76.55
- FBK 64.84
- Support Level
- IMCR $31.85
- FBK $52.66
- Resistance Level
- IMCR $33.08
- FBK $54.51
- Average True Range (ATR)
- IMCR 1.28
- FBK 1.08
- MACD
- IMCR 0.50
- FBK 0.08
- Stochastic Oscillator
- IMCR 100.00
- FBK 75.61
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.